Organization
Apcintex
3 clinical trials
Clinical trial
A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With InhibitorsStatus: Recruiting, Estimated PCD: 2025-09-08
Clinical trial
An Adaptive Design, Phase I/IIa, Open Label, Multicentre, Single Dose Escalation and Multiple Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous and Subcutaneous Doses of SerpinPC in Healthy Male Volunteers and Male Participants With Severe Haemophilia A or B With or Without InhibitorsStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BStatus: Recruiting, Estimated PCD: 2026-03-14